Currently, true-sale securitisations (i.e. securitisations in which the underlying receivables are transferred) which comply with the STS framework receive beneficial regulatory capital treatment. Conversely, there is no such STS framework in place in respect of synthetic securitisations (i.e. securitisations in which (a portion of) the risk exposure to the underlying receivables is transferred, but the underlying receivables are not) and so they do not receive such beneficial treatment.
However, Article 45 of the Securitisation Regulation requires the European Banking Authority (EBA) to publish a report on the feasibility of a STS framework, limited to balance-sheet synthetic securitisation. Pursuant to this, on 24 September 2019, the EBA published its discussion paper, “Draft Report on STS Framework for Synthetic Securitisation” (the EBA paper) and on 9 October 2019, the EBA held a public hearing on the same topic (the EBA hearing).
EBA paper – EBA recommendations
While the EBA paper does not provide any recommendations on any potential differentiated regulatory treatment, it does seek stakeholders’ input about the possibility, its potential impact and other considerations.
Under section 5.6 of the EBA paper, the EBA recommends:
- the establishment of a cross-sectoral STS framework, limited to balance-sheet securitisation; and
- that for any synthetic securitisation to be eligible as “STS”, it should comply with the criteria on simplicity, standardisation and transparency, and additional criteria specific to synthetic securitisation, as specified in section 5.4 of the EBA paper.
EBA hearing – pros and cons of the development of a STS framework for synthetic securitisations
Helpfully, the EBA Hearing presentation set out some of the pros and cons of the development of a STS framework for synthetic securitisations, as follows:
EBA hearing – pros and cons of the introduction of more risk-sensitive regulatory treatment of the STS framework-compliant product
In addition, the EBA Hearing presentation also set out some of the pros and cons of the introduction of a more risk-sensitive regulatory treatment of the STS framework-compliant product, as follows:
Do feel free to contact us to discuss the effect of the proposals.